EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum

Tanyaluck Kampoun, Pimpisid Koonyosying, Jetsada Ruangsuriya, Parichat Prommana, Philip J Shaw iD, Sumalee Kamchonwongpaisan, Hery Suwito, Ni Nyoman Tri Puspaningsih, Chairat Uthaipibull iD, Somdet Srichairatanakool

PeerJ · 2023

DOI: 10.7717/peerj.15187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Tanyaluck Kampoun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Antimalarials, Chalcone, Malaria, Falciparum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Golden Jubilee PhD Program, Thailand Research Fund, Faculty of Medicine Endowment Fund, Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The spread of artemisinin (ART)-resistant Plasmodium falciparum threatens the control of malaria. Mutations in the propeller domains of P. falciparum Kelch13 ( k13 ) are strongly associated with ART resistance. Ferredoxin (Fd), a component of the ferredoxin/NADP + reductase (Fd/FNR) redox system, is essential for isoprenoid precursor synthesis in the plasmodial apicoplast, which is important for K13-dependent hemoglobin trafficking and ART activation. Therefore, Fd is an antimalarial drug target and fd mutations may modulate ART sensitivity. We hypothesized that loss of Fd/FNR function enhances the effect of k13 mutation on ART resistance.

Methods

In this study, methoxyamino chalcone (C3), an antimalarial compound that has been reported to inhibit the interaction of recombinant Fd and FNR proteins, was used as a chemical inhibitor of the Fd/FNR redox system. We investigated the inhibitory effects of dihydroartemisinin (DHA), C3, and iron chelators including deferiprone (DFP), 1-( N -acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and deferiprone-resveratrol hybrid (DFP-RVT) against wild-type (WT), k13 mutant, fd mutant, and k13 fd double mutant P. falciparum parasites. Furthermore, we investigated the pharmacological interaction of C3 with DHA, in which the iron chelators were used as reference ART antagonists.

Results

C3 showed antimalarial potency similar to that of the iron chelators. As expected, combining DHA with C3 or iron chelators exhibited a moderately antagonistic effect. No differences were observed among the mutant parasites with respect to their sensitivity to C3, iron chelators, or the interactions of these compounds with DHA.

Discussion

The data suggest that inhibitors of the Fd/FNR redox system should be avoided as ART partner drugs in ART combination therapy for treating malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsChalconeMalaria, FalciparumHumansPlasmodium falciparumFerredoxinsDeferiproneFerredoxin-NADP ReductaseIron Chelating AgentsArtemisinins

Stichwörter der Autor:innen

AntimalarialArtemisininChalconeDrug resistanceFerredoxinHydroxypyridinonePlasmodium

Substanzen

AntimalarialsFerredoxinsChalconeDeferiproneFerredoxin-NADP ReductaseIron Chelating AgentsartenimolArtemisininsartemisinin

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, Thailand.
  • Department of Chemistry, Faculty of Science and Technology, Airlangga University, Surabaya, Indonesia.
  • Laboratory of Proteomics, University-CoE Research Center for Bio-Molecule Engineering, Universitas Airlangga, Surabaya, Indonesia.
  • Thailand Center of Excellence for Life Sciences (TCELS), Bangkok, Thailand.

ORCID-Profile: Philip J Shaw, Chairat Uthaipibull

Förderung

  • Royal Golden Jubilee PhD Program
  • Thailand Research Fund
  • Faculty of Medicine Endowment Fund, Chiang Mai University

Zitieren

APA

Kampoun, T., Koonyosying, P., Ruangsuriya, J., Prommana, P., Shaw, P. J., Kamchonwongpaisan, S., Suwito, H., Puspaningsih, N. N. T., Uthaipibull, C., & Srichairatanakool, S. (2023). Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum. PeerJ. https://doi.org/10.7717/peerj.15187

Vancouver

Kampoun T, Koonyosying P, Ruangsuriya J, Prommana P, Shaw PJ, Kamchonwongpaisan S, et al. Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum. PeerJ. 2023. doi:10.7717/peerj.15187

BibTeX
@article{Kampoun2023,
  author = {Kampoun, Tanyaluck and Koonyosying, Pimpisid and Ruangsuriya, Jetsada and Prommana, Parichat and Shaw, Philip J and Kamchonwongpaisan, Sumalee and Suwito, Hery and Puspaningsih, Ni Nyoman Tri and Uthaipibull, Chairat and Srichairatanakool, Somdet},
  title = {Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15187}
}
Kostenlos starten →